References
- Sweetman , S. C. 2002 . Martindale, The Complete Drug Reference , 33rd Ed. , Edited by: Sweetman , S. C. 81 London : Pharmaceutical Press .
- Walsh , P. M. 2000 . Physicians Desk Reference (PDR) , 54th Ed. , Edited by: Walsh , P. M. 1912 Montvale, NJ : Medical Economics Company Inc. .
- Sattari , S. and Jamali , F. 2000 . High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma . J. Pharm. Pharmaceut. Sci. , 3 : 312 – 316 .
- Chavez‐Eng , C. M. , Constanzer , M. L. and Matuszewski , B. K. 2000 . Determination of rofecoxib (MK‐0966), a cyclooxygenase‐2 inhibitor, in human plasma by high‐performance liquid chromatography with tandem mass spectrometric detection . J. Chromatogr. B , 748 : 31 – 39 .
- Werner , U. , Werner , D. , Mundkowski , R. , Gillich , M. and Brune , K. 2001 . Selective and rapid liquid chromatography‐mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans . J. Chromatogr. B , 760 : 83 – 90 .
- Mazenko , R. S. , Skarbek , A. , Woolf , E. J. , Simpson , R. C. and Matuszewski , B. K. 2001 . Sample preparation via solid phase extraction in the 9‐well fomat for HPLC/UV detection‐based biofluid assays. Application to the determination of a novel cyclooxygenase II inhibitor in human plasma and urine . J. Liq. Chromatogr. Rel. Tech. , 24 : 2601 – 2614 .
- Hsieh , J. Y. K. and Matuszewski , B. K. 2001 . High‐throughput liquid chromatographic determination of rofecoxib in human plasma using a fully automated on‐line solid‐phase extraction system . J. Liq. Chromatogr. Rel. Technol. , 24 : 799 – 812 .
- Vallano , P. T. , Mazenko , R. S. , Woolf , E. J. and Matuszewski , B. K. 2002 . Monolithic silica liquid chromatography columns for the determination of cyclooxygenase II inhibitors in human plasma . J. Chromatogr. B , 779 : 249 – 257 .
- Matthews , C. Z. , Woolf , E. J. and Matuszewski , B. K. 2002 . Improved procedure for the determination of rofecoxib in human plasma involving 96‐well solid‐phase extraction and fluorescence detection . J. Chromatogr. A , 949 : 83 – 89 .
- Woolf , E. , Fu , I. and Matuszewski , B. 1999 . Determination of Rofecoxib, a cyclooxygenase‐2 specific inhibitor, in human plasma using high performance liquid chromatography with post‐column photochemical derivatization and fluorescence detection . J. Chromatogr. B , 730 : 221 – 227 .
- Chavez‐Eng , C. M. , Constanzer , M. L. and Matuszewski , B. K. 2002 . High‐performance liquid chromatographic‐tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies . J. Chromatogr. B , 767 : 117 – 129 .
- Abdel‐Hamid , M. E. 2000 . LC‐MS analysis of selected sulfur‐containing non‐steroid anti‐inflammatory agents: applications to pharmaceutical products . J. Liq. Chromatogr. Rel. Technol. , 23 : 3095 – 3107 .
- Radhakrishna , T. , Rao , D. S. and Reddy , G. O. 2001 . LC determination of rofecoxib in bulk and pharmaceutical formulations . J. Pharm. Biomed. Anal. , 26 : 617 – 628 .
- Radi , A. 2002 . Adsorptive stripping square‐wave voltammetric behavior of rofecoxib . Microchem. J. , 72 : 35 – 41 .
- Rowe , S. R. and Carless , J. E. 1981 . Comparison at the in vitro behaviour of various indomethacin formulations with their in vivo bioavailability . J. Pharm. Pharmacol. , 33 : 561 – 565 .
- Anchisi , C. , Baroli , B. M. , Fadda , A. M. , Manconi , M. , Sinico , C. and Valenti , D. 1998 . Dissolution properties of flurazepam capsules . II Farmaco , 53 : 662 – 666 .
- Özkan , Y. , Özkan , S. A. and Aboul‐Enein , H. Y. 2001 . Determination of clenbuterol HCl in human serum and pharmaceuticals and drug dissolution studies by RP‐HPLC . J. Liq. Chromatogr. Rel. Techn. , 24 : 679 – 691 .
- Özkan , S. A. , Özkan , Y. and Aboul‐Enein , H. Y. 2002 . Quality control and drug dissolution studies of pharmaceutical preparations containing cerivastatin sodium by RP‐HPLC . J. Liq. Chromatogr. Rel. Techn. , 25 : 251 – 262 .
- Satiropoulus , B. , Deutsch , T. and Plakogiannis , F. M. 1981 . Comparative bioavailability of three commercial acetaminophen tablets . J. Pharm. Sci. , 70 : 422 – 425 .
- Uslu , B. and Özkan , S. A. 2002 . Determination of lamivudine and zidovudine in binary mixture using first derivative spectrophotometric, first derivative of the ratio spectra and HPLC‐UV methods . Anal. Chim. Acta , 466 : 175 – 185 .
- Özkan , S. A. and Uslu , B. 2002 . A rapid HPLC assay for the determination of lamivudine in pharmaceuticals and human serum . J. Liq. Chromatogr. Rel. Techn. , 25 : 1447 – 1456 .
- Özkan , Y. , Savaşer , A. , Taş , Ç. , Uslu , B. and Özkan , S. A. Drug dissolution studies and determination of deflazacort in pharmaceutical formulation and human serum samples by RP‐HPLC . J. Liq. Chromatogr. Rel. Techn. , 2003, in press
- Savaşer , A. , Özkan , C. K. , Özkan , Y. , Uslu , B. and Özkan , S. A. 2003 . Development and validation of a RP‐HPLC method for the determination of valacyclovir in tablets and human serum and its application to the drug dissolution studies . J. Liq. Chromatogr. Rel. Techn. , 26 : 1755 – 1767 .
- Swartz , M. E. and Krull , I. S. 1997 . Analytical Method Development and Validation , New York : Marcel Dekker .
- Riley , C. M. and Rosanske , T. W. 1996 . Development and Validation of Analytical Methods , New York : Elsevier Science Ltd .
- Halperin , J. A. 2000 . The United States Pharmacopoeia, The USP , 24th Ed. , Edited by: Halperin , J. A. Tounton, MA : Easton, Rand Mc Nally . [CD‐ROM]
- Higuchi , T. 1963 . Mechanism of sustained action medication . J. Pharm. Sci. , 52 : 1145 – 1149 .
- Langenbucher , F. 1976 . Parametric representation of dissolution rate curves by the RRSBW distribution . Pharm. Ind., Pharm. Ind. , 38 : 472 – 477 .
- Krosmeyer , R. W. , Gurny , R. , Doelker , E. , Buri , P. and Peppas , N. A. 1983 . Mechanisms of solute release from porous hydrophilic polymers . Int. J. Pharm. , 15 : 25 – 35 .
- Ritger , P. L. and Peppas , N. A. 1987 . A simple equation for description of solute release I. Fickian and non‐Fickian release from non‐swellable devices in the form of slabs, spheres, cylinders or discs . J. Cont. Rel. , 5 : 23 – 36 .